SUNY Downstate Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

  1. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

    The Lancet Child and Adolescent Health, Vol. 7, Núm. 3, pp. 180-189

  2. Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Children With Heart or Lung Disease

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 8, pp. 477-480

2022

  1. Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity

    New England Journal of Medicine

2020

  1. Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 6, pp. 1340-1347

2018

  1. Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients

    Journal of the American Academy of Dermatology, Vol. 78, Núm. 6, pp. 1102-1109